Live
Read now

TwinHeart

health AI/medtech/biotech (cardiovascular medical devices)
StageNot publicly disclosed/Early-stage startup founded in 2024
YC batchNot applicable/Not mentioned
RaisedNot publicly disclosed
Founded2024
Employees2
LocationHouston, TX
ValuationNot publicly disclosed

About

At TwinHeart, we are revolutionizing cardiac care for patients with advanced heart failure. Founded by Dr. Alexandru Plesoianu, our mission is to develop innovative, life-saving treatment solutions for the millions of patients worldwide who struggle with severe cardiac conditions. Our goal is to provide cutting-edge medical technology that addresses the critical needs of heart failure patients. Inspired by personal loss and driven by a passion for innovation, we are committed to transforming the landscape of cardiac treatment. The TwinHeart artificial heart stands at the forefront of our innovations. This groundbreaking, minimally invasive device is designed to be simple, durable, and cost-effective, reducing hospital expenses by 90% compared to existing technologies. It represents a significant advancement in the treatment of heart failure, making high-quality care accessible to more patients. - **Summa Cum Laude PhD & European Society of Artificial Organs Phd Silver Award**: Showcasing exceptional expertise in artificial heart research. - **Two Patents**: Reflecting dedication to innovation and protecting intellectual property. - **Over 20 Undisclosed Inventions**: Highlighting our ongoing commitment to research and development. - **Awards and Recognitions**: - "The Most Advanced Design" at the World HeartHackathon in Dallas, USA And Utsunomiya Japan; - "Medical Innovation of the Year" and "Excellence in Research" in Bucharest. We envision a future where TwinHeart technology saves 1 million lives each year, profoundly impacting the field of cardiac care. TwinHeart is dedicated to advancing cardiac care through relentless innovation, rigorous research, and a deep commitment to patient outcomes. Join us in our journey to redefine cardiac treatment and transform the lives of millions around the world.

Product

Value proposition
Minimally invasive, fully implantable, magnetically levitated partial-support LVAD to assist the native left ventricle with wireless energy, aiming to provide safer, more comfortable long-term therapy for advanced heart failure.
Regulatory
The device is under development - not market ready!

Founders

  • Alexandru Pleșoianu — Founder and CEO
  • Carmen Pleșoianu — CoFounder and CMO

Products

TwinHeart LVAD (left ventricular assist device)

Key features

minimally invasive implantationfully implantablemagnetically levitated centrifugal pumpwireless energy transfer (TET)no driveline infectionspreserves pulsatility2–4 L/min flowpacemaker-style implantation

Technologies

magnetic levitationcentrifugal pumptranscutaneous energy transfer (TET)

Target conditions

advanced heart failureheart failure without transplant or long-term mechanical support

Care settings

hospitalclinichome

Traction metrics

device under developmentaims to revitalizes quality of life for advanced heart failure patients

News

More links

Browse similar startups

Related startups

Profile updated Jul 29, 2026. Sources: twinheart.life

ClinAdsby ClinsightBuilt for clinics

Your clinic’s marketing team, powered by AI.

On-brand ads, SEO, and social campaigns in one place.

Generate your first clinic ad for free
Clincyby ClinsightBuilt for practices

Get more revenue from the patients you already have.

Voice and SMS that follow up until lapsed patients are back on the schedule.

Book a Clincy call
DDS RecruitPowered by ClinsightDental recruiting

Your practice’s fractional recruiting team.

Dental-only search, run end to end, with placements guaranteed for a year.

Find your next hire